PD-1 and PD-L1 expression is detectable in both PTCL and immune cells within the tumor microenvironment and forms the basis for the exploration of antibodies targeting these proteins. The gene discussed is CD274; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.